BioSpace News Archive

ASRS Top 10 awarded to Palatin’s pre-clinical diabetic retinopathy poster demonstrating positive effects of melanocortin agonists for retinal inflammation

Nutriband Inc. is pleased to announce the receipt of $2,062,500 in additional gross from the exercise of warrants issued in the Company’s October 1, 2021 public offering of securities.

Aadi Bioscience, Inc. today announced the publication of “ nab -Sirolimus for Patients with Malignant Perivascular Epithelioid Cell Tumors”, detailing its AMPECT study of investigational ABI-009 in the American Society of Clinical Oncology’s Journal of Clinical Oncology

Palisade Bio, Inc. announces today that an early exercise option has led to the acquisition of the Seneca asset NSI-189

Sun Nuclear, part of Mirion Technologies, announced today that during the 2021 ASTRO Annual Meeting , October 24-26 in Chicago, Illinois

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its third-quarter 2021 financial results on Tuesday, November 2, 2021 after the financial markets close.

Evolus, Inc. today announced that it will report its third quarter 2021 financial results and provide a business update on Tuesday, November 2, 2021, prior to the open of the U.S. financial markets.

Cal State LA has received a $100,000 grant from the Amgen Foundation to establish the community education component of the Cal State LA BioSpace incubator, which is leading the university’s efforts to promote a thriving bioscience ecosystem in the heart of Los Angeles.

Context Therapeutics Inc. (the “Company”) (Nasdaq: CNTX), a women’s oncology company developing advanced small molecule and immunotherapy treatments to transform care for hormone-driven breast and gynecological cancers, today announced the closing of its initial public offering of 5,750,000 shares of its common stock at a public offering price of $5.00 per share.

Healthcare Trust of America, Inc. (the “Company”) (NYSE: HTA), announced today that on Thursday, November 4, 2021, after the market closes, HTA will report its financial results for the three months ending September 30, 2021.